Skip to main content

A brain tumor is a complex and multi-faceted disease with unknown etiology. In order to find a cure, we need to discover the tumor’s inception, structure and nature in order to find the best possible treatment to help you live a long and fulfilling life.

Clinical trials are research studies that test new cancer drugs, diagnostic procedures and therapies on humans. A clinical trial is one of the final stages of a long and careful cancer research process. The trial will translate promising findings from basic research into benefits for our patients. Studies are conducted with brain cancer patients in controlled environments and under the ethical and regulatory oversight of the Institutional Review Boards. If you are interested in participating in a clinical trial at the UNC Lineberger Comprehensive Cancer Center, please visit our Clinical Research website.

UNC’s Neuro-Oncology program also belongs to three brain tumor research consortia: Brain Tumor Trials Collaborative (BTTC), the Alliance (Alliance for Clinical Trials in Oncology), and CERN (Collaborative Ependymoma Research Network). The consortia consist of prestigious and well-respected cancer centers across the country working together and sharing their findings for a common goal: to advance treatment for patients who suffer from brain cancers.

For more information, please contact:

Simon Khagi, MD
Neurological Oncologist
Director, UNC Brain Tumor Program
(984) 974-8415